SciELO - Scientific Electronic Library Online

vol.12 issue7Factors related to survival from oral cancer in an Andalusian population sample (Spain)Distraction osteogenesis in Goldenhar Syndrome: Case report and 8-year follow-up author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google


Medicina Oral, Patología Oral y Cirugía Bucal (Internet)

On-line version ISSN 1698-6946


BONAN, Paulo Rogério Ferreti et al. Effectiveness of low flow vascular lesions sclerosis with monoetanolamine: Report of six cases. Med. oral patol. oral cir.bucal (Internet) [online]. 2007, vol.12, n.7, pp.524-527. ISSN 1698-6946.

Vascular malformations or even hemangiomas need therapeutic intervention if they start to cause clinical symptoms or personal discomfort. Different therapeutic modalities, including cryotherapy, corticosteroids, laser therapy, sclerotherapy, surgery, and/or embolization, can be performed successfully. Sclerotherapy with monoethanolamine is a relatively simple and effective method to treat low flow vascular lesions. We presented a report of six cases of vascular malformations treated with monoethanolamine. There were 3 male and 3 female patients, with an age range of 20 to 68 years. The patients were submitted to applications according to clinical response and/or tolerability. In all cases, low-flow vascular lesions were recorded and submitted to infiltration with 2.5% monoethanolamine, directly into the lesions. The volume applied was approximately the middle of affected area. Vascular lesions were characterized as low-flow due to absence of arterial pulsation and flat consistence. The sclerosis with 2.5% monoethanolamine resulted in complete or partial involution, without severe complications.

Keywords : Vascular lesions; sclerotherapy; monoethanolamine; hemangioma.

        · text in English     · English ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License